AMPHENOL CORP-CL A (XPH.DE) Fundamental Analysis & Valuation

FRA:XPH • US0320951017

115.38 EUR
-2.64 (-2.24%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This XPH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to XPH. XPH was compared to 55 industry peers in the Electronic Equipment, Instruments & Components industry. Both the health and profitability get an excellent rating, making XPH a very profitable company, without any liquidiy or solvency issues. XPH is valued quite expensive, but it does show an excellent growth. With these ratings, XPH could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. XPH.DE Profitability Analysis

1.1 Basic Checks

  • XPH had positive earnings in the past year.
  • XPH had a positive operating cash flow in the past year.
  • Each year in the past 5 years XPH has been profitable.
  • In the past 5 years XPH always reported a positive cash flow from operatings.
XPH.DE Yearly Net Income VS EBIT VS OCF VS FCFXPH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • XPH's Return On Assets of 11.78% is amongst the best of the industry. XPH outperforms 94.55% of its industry peers.
  • The Return On Equity of XPH (31.84%) is better than 98.18% of its industry peers.
  • XPH has a Return On Invested Capital of 16.23%. This is amongst the best in the industry. XPH outperforms 96.36% of its industry peers.
  • XPH had an Average Return On Invested Capital over the past 3 years of 15.52%. This is significantly above the industry average of 7.76%.
  • The last Return On Invested Capital (16.23%) for XPH is above the 3 year average (15.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.78%
ROE 31.84%
ROIC 16.23%
ROA(3y)11.59%
ROA(5y)11.6%
ROE(3y)26.56%
ROE(5y)26.41%
ROIC(3y)15.52%
ROIC(5y)15.38%
XPH.DE Yearly ROA, ROE, ROICXPH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 18.49%, XPH belongs to the best of the industry, outperforming 98.18% of the companies in the same industry.
  • XPH's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 26.20%, XPH belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of XPH has grown nicely.
  • XPH has a Gross Margin of 37.22%. This is comparable to the rest of the industry: XPH outperforms 49.09% of its industry peers.
  • XPH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.2%
PM (TTM) 18.49%
GM 37.22%
OM growth 3Y8.24%
OM growth 5Y6.42%
PM growth 3Y7.06%
PM growth 5Y5.73%
GM growth 3Y5.26%
GM growth 5Y3.74%
XPH.DE Yearly Profit, Operating, Gross MarginsXPH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. XPH.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so XPH is creating value.
  • The number of shares outstanding for XPH has been increased compared to 1 year ago.
  • Compared to 5 years ago, XPH has more shares outstanding
  • XPH has a worse debt/assets ratio than last year.
XPH.DE Yearly Shares OutstandingXPH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
XPH.DE Yearly Total Debt VS Total AssetsXPH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • XPH has an Altman-Z score of 6.33. This indicates that XPH is financially healthy and has little risk of bankruptcy at the moment.
  • XPH has a Altman-Z score of 6.33. This is amongst the best in the industry. XPH outperforms 85.45% of its industry peers.
  • The Debt to FCF ratio of XPH is 3.54, which is a good value as it means it would take XPH, 3.54 years of fcf income to pay off all of its debts.
  • XPH's Debt to FCF ratio of 3.54 is fine compared to the rest of the industry. XPH outperforms 69.09% of its industry peers.
  • XPH has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.09, XPH is doing worse than 85.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 3.54
Altman-Z 6.33
ROIC/WACC1.85
WACC8.77%
XPH.DE Yearly LT Debt VS Equity VS FCFXPH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 2.98 indicates that XPH has no problem at all paying its short term obligations.
  • XPH has a better Current ratio (2.98) than 89.09% of its industry peers.
  • XPH has a Quick Ratio of 2.48. This indicates that XPH is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.48, XPH belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.98
Quick Ratio 2.48
XPH.DE Yearly Current Assets VS Current LiabilitesXPH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. XPH.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.72% over the past year.
  • The Earnings Per Share has been growing by 29.00% on average over the past years. This is a very strong growth
  • XPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.71%.
  • XPH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.85% yearly.
EPS 1Y (TTM)76.72%
EPS 3Y30.58%
EPS 5Y29%
EPS Q2Q%76.36%
Revenue 1Y (TTM)51.71%
Revenue growth 3Y22.31%
Revenue growth 5Y21.85%
Sales Q2Q%49.13%

3.2 Future

  • XPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.50% yearly.
  • The Revenue is expected to grow by 15.26% on average over the next years. This is quite good.
EPS Next Y31.94%
EPS Next 2Y24.21%
EPS Next 3Y19.81%
EPS Next 5Y20.5%
Revenue Next Year37.21%
Revenue Next 2Y23.98%
Revenue Next 3Y18.57%
Revenue Next 5Y15.26%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XPH.DE Yearly Revenue VS EstimatesXPH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
XPH.DE Yearly EPS VS EstimatesXPH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

2

4. XPH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • XPH is valuated quite expensively with a Price/Earnings ratio of 39.92.
  • Compared to the rest of the industry, the Price/Earnings ratio of XPH is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 26.29. XPH is valued rather expensively when compared to this.
  • XPH is valuated quite expensively with a Price/Forward Earnings ratio of 30.27.
  • XPH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. XPH is more expensive than 60.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of XPH to the average of the S&P500 Index (24.60), we can say XPH is valued slightly more expensively.
Industry RankSector Rank
PE 39.92
Fwd PE 30.27
XPH.DE Price Earnings VS Forward Price EarningsXPH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, XPH is valued a bit more expensive than the industry average as 61.82% of the companies are valued more cheaply.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of XPH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.45
EV/EBITDA 24.06
XPH.DE Per share dataXPH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • XPH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • XPH has an outstanding profitability rating, which may justify a higher PE ratio.
  • XPH's earnings are expected to grow with 19.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.25
PEG (5Y)1.38
EPS Next 2Y24.21%
EPS Next 3Y19.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. XPH.DE Dividend Analysis

5.1 Amount

  • XPH has a yearly dividend return of 0.73%, which is pretty low.
  • XPH's Dividend Yield is comparable with the industry average which is at 1.50.
  • Compared to an average S&P500 Dividend Yield of 1.82, XPH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

  • The dividend of XPH has a limited annual growth rate of 5.75%.
Dividend Growth(5Y)5.75%
Div Incr Years0
Div Non Decr Years0
XPH.DE Yearly Dividends per shareXPH.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 18.79% of the earnings are spent on dividend by XPH. This is a low number and sustainable payout ratio.
  • XPH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP18.79%
EPS Next 2Y24.21%
EPS Next 3Y19.81%
XPH.DE Yearly Income VS Free CF VS DividendXPH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
XPH.DE Dividend Payout.XPH.DE Dividend Payout, showing the Payout Ratio.XPH.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

XPH.DE Fundamentals: All Metrics, Ratios and Statistics

AMPHENOL CORP-CL A

FRA:XPH (3/6/2026, 7:00:00 PM)

115.38

-2.64 (-2.24%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-29
Inst Owners97.74%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap141.83B
Revenue(TTM)23.09B
Net Income(TTM)4.27B
Analysts78.4
Price Target143.67 (24.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0.57
Dividend Growth(5Y)5.75%
DP18.79%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.26%
Min EPS beat(2)2.85%
Max EPS beat(2)15.68%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.85%
Max EPS beat(4)20.94%
EPS beat(8)8
Avg EPS beat(8)11.76%
EPS beat(12)12
Avg EPS beat(12)9.28%
EPS beat(16)16
Avg EPS beat(16)8.65%
Revenue beat(2)2
Avg Revenue beat(2)6.94%
Min Revenue beat(2)3.02%
Max Revenue beat(2)10.85%
Revenue beat(4)4
Avg Revenue beat(4)9.38%
Min Revenue beat(4)3.02%
Max Revenue beat(4)12.54%
Revenue beat(8)8
Avg Revenue beat(8)7.19%
Revenue beat(12)12
Avg Revenue beat(12)5.69%
Revenue beat(16)16
Avg Revenue beat(16)5.42%
PT rev (1m)1.17%
PT rev (3m)12.14%
EPS NQ rev (1m)0.58%
EPS NQ rev (3m)12.3%
EPS NY rev (1m)0.13%
EPS NY rev (3m)6.29%
Revenue NQ rev (1m)1.19%
Revenue NQ rev (3m)18.24%
Revenue NY rev (1m)1.48%
Revenue NY rev (3m)14.32%
Valuation
Industry RankSector Rank
PE 39.92
Fwd PE 30.27
P/S 7.1
P/FCF 37.45
P/OCF 30.51
P/B 12.22
P/tB 274.97
EV/EBITDA 24.06
EPS(TTM)2.89
EY2.5%
EPS(NY)3.81
Fwd EY3.3%
FCF(TTM)3.08
FCFY2.67%
OCF(TTM)3.78
OCFY3.28%
SpS16.25
BVpS9.44
TBVpS0.42
PEG (NY)1.25
PEG (5Y)1.38
Graham Number24.77
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 31.84%
ROCE 20.55%
ROIC 16.23%
ROICexc 26.54%
ROICexgc 92.17%
OM 26.2%
PM (TTM) 18.49%
GM 37.22%
FCFM 18.96%
ROA(3y)11.59%
ROA(5y)11.6%
ROE(3y)26.56%
ROE(5y)26.41%
ROIC(3y)15.52%
ROIC(5y)15.38%
ROICexc(3y)20.88%
ROICexc(5y)19.32%
ROICexgc(3y)67.82%
ROICexgc(5y)59.81%
ROCE(3y)19.66%
ROCE(5y)19.48%
ROICexgc growth 3Y21.8%
ROICexgc growth 5Y15.1%
ROICexc growth 3Y13.08%
ROICexc growth 5Y11.04%
OM growth 3Y8.24%
OM growth 5Y6.42%
PM growth 3Y7.06%
PM growth 5Y5.73%
GM growth 3Y5.26%
GM growth 5Y3.74%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 3.54
Debt/EBITDA 2.09
Cap/Depr 108.04%
Cap/Sales 4.32%
Interest Coverage 21
Cash Conversion 77.09%
Profit Quality 102.52%
Current Ratio 2.98
Quick Ratio 2.48
Altman-Z 6.33
F-Score7
WACC8.77%
ROIC/WACC1.85
Cap/Depr(3y)105.34%
Cap/Depr(5y)100.96%
Cap/Sales(3y)3.89%
Cap/Sales(5y)3.6%
Profit Quality(3y)101%
Profit Quality(5y)94.26%
High Growth Momentum
Growth
EPS 1Y (TTM)76.72%
EPS 3Y30.58%
EPS 5Y29%
EPS Q2Q%76.36%
EPS Next Y31.94%
EPS Next 2Y24.21%
EPS Next 3Y19.81%
EPS Next 5Y20.5%
Revenue 1Y (TTM)51.71%
Revenue growth 3Y22.31%
Revenue growth 5Y21.85%
Sales Q2Q%49.13%
Revenue Next Year37.21%
Revenue Next 2Y23.98%
Revenue Next 3Y18.57%
Revenue Next 5Y15.26%
EBIT growth 1Y84.21%
EBIT growth 3Y32.39%
EBIT growth 5Y29.68%
EBIT Next Year56.95%
EBIT Next 3Y24.85%
EBIT Next 5Y18.43%
FCF growth 1Y103.7%
FCF growth 3Y34.71%
FCF growth 5Y27.19%
OCF growth 1Y90.95%
OCF growth 3Y35.2%
OCF growth 5Y27.55%

AMPHENOL CORP-CL A / XPH.DE FAQ

What is the fundamental rating for XPH stock?

ChartMill assigns a fundamental rating of 7 / 10 to XPH.DE.


What is the valuation status for XPH stock?

ChartMill assigns a valuation rating of 2 / 10 to AMPHENOL CORP-CL A (XPH.DE). This can be considered as Overvalued.


How profitable is AMPHENOL CORP-CL A (XPH.DE) stock?

AMPHENOL CORP-CL A (XPH.DE) has a profitability rating of 9 / 10.


What are the PE and PB ratios of AMPHENOL CORP-CL A (XPH.DE) stock?

The Price/Earnings (PE) ratio for AMPHENOL CORP-CL A (XPH.DE) is 39.92 and the Price/Book (PB) ratio is 12.22.


What is the expected EPS growth for AMPHENOL CORP-CL A (XPH.DE) stock?

The Earnings per Share (EPS) of AMPHENOL CORP-CL A (XPH.DE) is expected to grow by 31.94% in the next year.